May 23, 2023 07:32AM
May 23, 2023 07:30AM
May 23, 2023 07:30AM
Dec 13, 2022 11:48AM
Nov 8, 2022 04:03PM
Nov 8, 2022 04:03PM
May 16, 2022 04:01PM CohBar Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress
May 16, 2022 04:01PM
Nov 15, 2021 04:02PM
Nov 15, 2021 04:02PM
Sep 8, 2021 09:02AM
Sep 8, 2021 09:00AM
Sep 8, 2021 09:00AM
Oct 29, 2020 09:00AM CohBar to Host Key Opinion Leader Meeting on Antifibrotic Peptides for the Potential Treatment of Idiopathic Pulmonary Fibrosis
Oct 29, 2020 09:00AM
May 7, 2019 09:03AM
May 7, 2019 09:00AM
May 7, 2019 09:00AM
May 3, 2019 09:02AM
May 3, 2019 09:00AM
May 3, 2019 09:00AM CohBar to Resume its Phase 1a/1b Clinical Trial
Mar 18, 2019 04:03PM
Mar 18, 2019 04:03PM
Nov 26, 2018 09:00AM
Nov 26, 2018 09:00AM
Nov 14, 2018 04:03PM
Nov 14, 2018 04:03PM
Mar 29, 2017 05:33PM CohBar, Inc.’s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York
Feb 21, 2017 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All